Prodesse, Inc.
W229 N1870 Westwood Drive
Waukesha
Wisconsin
53186
United States
Tel: 262-446-0700-Or-888-589-6974
Fax: 262-446-0600
Website: http://www.prodesseinc.com/
41 articles about Prodesse, Inc.
-
Prodesse, Inc.'s ProAdeno+ Assay Cleared for US Marketing by FDA
12/9/2010
-
FDA Clears Prodesse, Inc.'s ProFAST+ Assay to Identify Three Strains of Influenza A, Including 2009 H1N1
7/27/2010
-
Prodesse, Inc.'s ProParaflu+(TM) Assay Cleared for US Marketing by FDA
11/25/2009
-
FDA Grants Emergency Use Authorization of the Prodesse, Inc. ProFlu-ST(TM)
10/29/2009
-
Gen-Probe Incorporated Completes Acquisition of Prodesse, Inc., Leader in Molecular Testing for Respiratory Infectious Diseases
10/23/2009
-
Gen-Probe Incorporated (JOBS) to Acquire Flu Test Maker, Prodesse, Inc. for $60 Million
10/8/2009
-
Prodesse, Inc. Acquires Non-Exclusive U.S. Distribution Rights for Cepheid SmartCycler(R) System
9/23/2009
-
Prodesse, Inc. Receives Special 510(k) for ProFlu+(TM) Assay Test Correctly Identifies 2009 H1N1 Influenza Virus as Influenza A
8/24/2009
-
Prodesse, Inc. Announces Licensure of Two Additional Patents
7/1/2009
-
Kevin T. Conroy, Former Third Wave Technologies, Inc. CEO, Joins Prodesse, Inc. Board
5/13/2009
-
Multiple Centers for Disease Control and Prevention (CDC) Confirmed Cases Initially Detected by Prodesse, Inc.'s ProFlu+
5/4/2009
-
Prodesse, Inc. Statement on ProFlu+(TM) and Swine Flu
4/28/2009
-
Prodesse, Inc.'s ProParaflu+(TM) Submitted to FDA for 510(k) Clearance
4/14/2009
-
Prodesse, Inc.’s ProGastro(TM) Cd for Detection of Clostridium difficile Submitted to FDA for 510(k) Clearance
2/3/2009
-
Prodesse, Inc.'s RT-PCR Pro hMPV+ Assay Receives FDA Clearance; The First Real-Time Cleared Assay for Human Metapneumovirus
11/12/2008
-
Prodesse, Inc. Submits Pro hMPV+(TM) Assay to FDA for 510(k) Clearance
9/17/2008
-
Prodesse, Inc. Releases CE Marked Multiplex PCR Assay in Europe for Detection of Parainfluenza Virus
9/9/2008
-
Prodesse, Inc. Releases CE Marked PCR Assay in Europe for Detection of Human Metapneumovirus
6/23/2008
-
Prodesse, Inc. Begins Clinical Trials for ProParaflu+™; the Company’s 4th Real-Time PCR Assay to Begin the 510(k) Clearance Process
6/4/2008
-
Quidel Corporation and Prodesse, Inc. Announce Flu and RSV Molecular Partnership
5/20/2008